Cefdinir Oral Presentations Shortage

• • Cefdinir oral capsule, Teva, 300 mg, bottle, 60 count, NDC 00093-3160-06
  • Cefdinir oral suspension, Teva, 125 mg/5 mL, 100 mL bottle, NDC 00093-4136-73
  • Cefdinir oral suspension, Teva, 125 mg/5 mL, 60 mL bottle, NDC 00093-4136-64
  • Cefdinir oral suspension, Teva, 250 mg/5 mL, 60 mL bottle, NDC 00093-4137-64

• • Ascend has cefdinir oral presentations available.
  • Aurobindo refuses to provide availability information.
  • Lupin has cefdinir presentations available.
  • Rising is shipping to forecast.
  • Teva did not provide a reason for the shortage.

• • Cefdinir oral capsule, Ascend, 300 mg, bottle, 60 count, NDC 67877-0543-60
  • Cefdinir oral suspension, Ascend, 125 mg/5 mL, 100 mL bottle, NDC 67877-0547-88
  • Cefdinir oral suspension, Ascend, 125 mg/5 mL, 60 mL bottle, NDC 67877-0547-98
  • Cefdinir oral suspension, Ascend, 250 mg/5 mL, 100 mL bottle, NDC 67877-0548-88
  • Cefdinir oral suspension, Ascend, 250 mg/5 mL, 60 mL bottle, NDC 67877-0548-98
  • Cefdinir oral capsule, Lupin, 300 mg, bottle, 60 count, NDC 68180-0711-60
  • Cefdinir oral suspension, Lupin, 125 mg/5 mL, 100 mL bottle, NDC 68180-0722-05
  • Cefdinir oral suspension, Lupin, 125 mg/5 mL, 60 mL bottle, NDC 68180-0722-04
  • Cefdinir oral suspension, Lupin, 250 mg/5 mL, 100 mL bottle, NDC 68180-0723-05
  • Cefdinir oral suspension, Lupin, 250 mg/5 mL, 60 mL bottle, NDC 68180-0723-04
  • Cefdinir oral capsule, Rising Pharmaceuticals, 300 mg, bottle, 60 count, NDC 57237-0099-60
  • Cefdinir oral suspension, Teva, 250 mg/5 mL, 100 mL bottle, NDC 00093-4137-73

Estimated Resupply Dates

• • Teva has cefdinir 125 mg/5 mL suspension in 60 mL and 100 mL bottles, and 250 mg/5 mL suspension in 60 mL bottles on back order and the company estimates a release date of late-August. The 300 mg capsules in 60 count bottles are on back order and the company estimates a release date of early-September.